NCT04003012View on ClinicalTrials.gov

Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 19, 2019

Primary Completion Date

July 20, 2021

Study Completion Date

July 20, 2021

Conditions
Leukemia-Lymphoma
Interventions
DRUG

EMLA

EMLA cream (lidocaine 2.5% and prilocaine 2.5%)

DRUG

Lidocaine

lidocaine 1%

Trial Locations (1)

25302

CAMC - Women and Children's Hospital, Charleston

All Listed Sponsors
lead

CAMC Health System

OTHER

NCT04003012 - Pain Control in Pediatric Oncology: Utility of EMLA Cream vs Lidocaine Injection in Lumbar Punctures | Biotech Hunter | Biotech Hunter